Hangzhou Coco Healthcare Products Co.,Ltd.
符号: 301009.SZ
SHZ
9.21
CNY今天的市场价格
89.9693
市盈率
0.0000
PEG比率
2.50B
MRK市值
- 0.00%
DIV收益率
Hangzhou Coco Healthcare Products Co.,Ltd. (301009-SZ) 财务报表
资产负债表
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 863.1 | 689.5 | 884 | |||||||
balance-sheet.row.short-term-investments | 0 | -20.4 | -21.2 | -23.5 | |||||||
balance-sheet.row.net-receivables | 0 | 213 | 274.5 | 188.2 | |||||||
balance-sheet.row.inventory | 0 | 114.8 | 182.4 | 153.9 | |||||||
balance-sheet.row.other-current-assets | 0 | 13.9 | 12.2 | 27.6 | |||||||
balance-sheet.row.total-current-assets | 0 | 1204.7 | 1158.5 | 1253.8 | |||||||
balance-sheet.row.property-plant-equipment-net | 0 | 663.4 | 670.4 | 694.8 | |||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.intangible-assets | 0 | 82.5 | 84.9 | 87 | |||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 82.5 | 84.9 | 87 | |||||||
balance-sheet.row.long-term-investments | 0 | 30.1 | 21.5 | 23.7 | |||||||
balance-sheet.row.tax-assets | 0 | 10.1 | 8.2 | 2.1 | |||||||
balance-sheet.row.other-non-current-assets | 0 | 1.2 | 5.2 | 24.2 | |||||||
balance-sheet.row.total-non-current-assets | 0 | 787.3 | 790.1 | 831.8 | |||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.total-assets | 0 | 1992 | 1948.6 | 2085.6 | |||||||
balance-sheet.row.account-payables | 0 | 439 | 429.9 | 528.5 | |||||||
balance-sheet.row.short-term-debt | 0 | 6.2 | 1.4 | 1.5 | |||||||
balance-sheet.row.tax-payables | 0 | 5.5 | 6.5 | 1.4 | |||||||
balance-sheet.row.long-term-debt-total | 0 | 11.9 | 3.3 | 5.1 | |||||||
Deferred Revenue Non Current | 0 | 45.2 | 39.1 | 6.8 | |||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||
balance-sheet.row.other-current-liab | 0 | 0.6 | 0.8 | 0.6 | |||||||
balance-sheet.row.total-non-current-liabilities | 0 | 57.1 | 42.3 | 11.9 | |||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.capital-lease-obligations | 0 | 11.9 | 3.3 | 5.1 | |||||||
balance-sheet.row.total-liab | 0 | 542.4 | 516.9 | 578.6 | |||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.common-stock | 0 | 271.9 | 271.9 | 271.9 | |||||||
balance-sheet.row.retained-earnings | 0 | 300.4 | 284.3 | 348.8 | |||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 73.2 | 70.8 | |||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 800.4 | 723.2 | 723.2 | |||||||
balance-sheet.row.total-stockholders-equity | 0 | 1372.7 | 1352.6 | 1414.7 | |||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1992 | 1948.6 | 2085.6 | |||||||
balance-sheet.row.minority-interest | 0 | 76.9 | 79.2 | 92.3 | |||||||
balance-sheet.row.total-equity | 0 | 1449.6 | 1431.8 | 1507 | |||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||
Total Investments | 0 | 9.7 | 0.3 | 0.3 | |||||||
balance-sheet.row.total-debt | 0 | 18.1 | 4.6 | 6.6 | |||||||
balance-sheet.row.net-debt | 0 | -845 | -684.8 | -877.4 |
现金流量表
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -56.2 | 39.4 | 223.1 | ||||||
cash-flows.row.depreciation-and-amortization | 0 | 61.3 | 49.4 | 39.2 | ||||||
cash-flows.row.deferred-income-tax | 0 | -6.1 | 3.8 | -3.6 | ||||||
cash-flows.row.stock-based-compensation | 0 | 6.1 | -3.8 | 3.6 | ||||||
cash-flows.row.change-in-working-capital | 0 | -110.7 | -53.8 | 67.3 | ||||||
cash-flows.row.account-receivables | 0 | -31 | 114.1 | -101.2 | ||||||
cash-flows.row.inventory | 0 | -40.2 | -34 | 4.5 | ||||||
cash-flows.row.account-payables | 0 | -33.5 | -137.7 | 167.6 | ||||||
cash-flows.row.other-working-capital | 0 | -6.1 | 3.8 | -3.6 | ||||||
cash-flows.row.other-non-cash-items | 0 | 68.5 | 15.4 | 66.2 | ||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -116.4 | -240.4 | -220.7 | ||||||
cash-flows.row.acquisitions-net | 0 | 0.6 | 25 | 0.1 | ||||||
cash-flows.row.purchases-of-investments | 0 | -65 | -95 | -150.3 | ||||||
cash-flows.row.sales-maturities-of-investments | 0 | 65.2 | 220.1 | 51.1 | ||||||
cash-flows.row.other-investing-activites | 0 | 3.4 | -24.5 | 8.3 | ||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -112.1 | -114.9 | -311.5 | ||||||
cash-flows.row.debt-repayment | 0 | 0 | -149.1 | -80.6 | ||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.dividends-paid | 0 | -19 | -0.9 | -23.6 | ||||||
cash-flows.row.other-financing-activites | 0 | -30.8 | 833.8 | 132.7 | ||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -49.9 | 683.8 | 28.5 | ||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 4.2 | -2.6 | -11.6 | ||||||
cash-flows.row.net-change-in-cash | 0 | -195 | 616.8 | 101.2 | ||||||
cash-flows.row.cash-at-end-of-period | 0 | 639.5 | 834.4 | 217.6 | ||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 834.4 | 217.6 | 116.4 | ||||||
cash-flows.row.operating-cash-flow | 0 | -37.2 | 50.5 | 395.9 | ||||||
cash-flows.row.capital-expenditure | 0 | -116.4 | -240.4 | -220.7 | ||||||
cash-flows.row.free-cash-flow | 0 | -153.6 | -189.9 | 175.1 |
利润表行
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1081.5 | 1186.3 | 1186.4 | |||||||
income-statement-row.row.cost-of-revenue | 0 | 890.6 | 1030.9 | 965.3 | |||||||
income-statement-row.row.gross-profit | 0 | 190.9 | 155.4 | 221.1 | |||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.other-expenses | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.operating-expenses | 0 | 175.2 | 171.3 | 176.8 | |||||||
income-statement-row.row.cost-and-expenses | 0 | 1065.7 | 1202.2 | 1142.1 | |||||||
income-statement-row.row.interest-income | 0 | 24.2 | 23.3 | 12.6 | |||||||
income-statement-row.row.interest-expense | 0 | 0.7 | 0.3 | 1 | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.total-other-income-expensenet | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||
income-statement-row.row.other-operating-expenses | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.total-operating-expenses | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.interest-expense | 0 | 0.7 | 0.3 | 1 | |||||||
income-statement-row.row.depreciation-and-amortization | 0 | 56.8 | 61.3 | 49.4 | |||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||
income-statement-row.row.operating-income | 0 | 20.2 | -55.5 | 45.3 | |||||||
income-statement-row.row.income-before-tax | 0 | 19.5 | -56.4 | 43.5 | |||||||
income-statement-row.row.income-tax-expense | 0 | 1.7 | -0.1 | 4.1 | |||||||
income-statement-row.row.net-income | 0 | 20.2 | -43.1 | 39.7 |
常见问题
什么是 Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) 总资产是多少?
Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) 总资产为 1992017074.000.
什么是企业年收入?
年收入为 N/A.
企业利润率是多少?
公司利润率为 0.187.
什么是公司自由现金流?
自由现金流为 0.539.
什么是企业净利润率?
净利润率为 0.026.
企业总收入是多少?
总收入为 0.028.
什么是 Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) 净利润?{{符号}}净利润(净收入)是多少?
净利润(净收入)为 20184911.000.
公司总债务是多少?
债务总额为 18052009.000.
营业费用是多少?
运营支出为 175169142.000.
公司现金是多少?
企业现金为 0.000.